News | June 02, 2014

CivaTech Oncology’s Linear Brachytherapy Device Added to AAPM Source Registry

June 2, 2014 — CivaTech Oncology’s flagship product, the CivaString source, has been listed on the Joint American Association of Physicists in Medicine/IROC Houston Registry of Brachytherapy Sources meeting the AAPM Dosimetric Prerequisites. This approval is granted through independent investigations and a thorough review process, affirming the robust dosimetric qualities of CivaString and allowing routine product use without special approvals or IRB clinical trial oversight.

This new method of polymer encapsulation of Palladium 103, a low dose rate source with a half–life of 17 days, enables a linear, homogenous dose profile which is designed to be superior to other products encapsulated in metals. CivaString is currently in use for the treatment of prostate cancer.

Suzanne Babcock, CivaTech Oncology chairman and CEO, said, “We are excited to see that both research and clinical usage suggest potential savings of up to 40 percent fewer needles than traditionally required for seed implants. This can result in reductions in tissue trauma and procedural time.” Other advantages of polymer-based brachytherapy include improvement to image quality, should patients require future diagnostics in the region.

The American Cancer Society estimates that in 2014, 233,000 new cases of prostate cancer will be diagnosed and 29,480 men will die of the disease. It is the second leading cause of cancer death among men in the United States. Most men are concerned about the undesirable side effects that accompany all methods of treating prostate cancer and the polymer-based technology may reduce some of these issues.

For more information: www.civatechoncology.com

Related Content

Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...
Videos | Radiation Therapy | August 01, 2018
This is an example of how Cherenkov radiation glow can be collected with image intensifier cameras during radiotherap
Videos | Artificial Intelligence | August 01, 2018
A discussion with Steve Jiang, Ph.D., director of the medical...
Videos | AAPM | August 01, 2018
American Association of Physicists in Medicine (AAPM) President Bruce Thomadsen, M.D., professor of medical physics a
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Overlay Init